Market Overview

The global enteral feeding devices market size was valued at USD 4.2 Billion in 2024. It is projected to reach USD 6.8 Billion by 2033, growing at a CAGR of 5.38% from 2025 to 2033. Enteral feeding devices deliver nutrients directly into the digestive tract through feeding tubes, crucial for patients who have difficulties with oral intake. The market growth is driven by the rising prevalence of chronic diseases, increasing elderly population, and technological advancements enhancing device comfort and functionality.

Study Assumption Years

• Base Year: 2024

• Historical Year/Period: 2019-2024

• Forecast Year/Period: 2025-2033

Enteral Feeding Devices Market Key Takeaways

• The enteral feeding devices market size was USD 4.2 Billion in 2024.

• The CAGR during the forecast period 2025-2033 is 5.38%.

• The market is projected to reach USD 6.8 Billion by 2033.

• Enteral feeding devices are essential for patients with difficulties in oral intake of food, liquids, and nutritional supplements.

• Novel silicon-based feeding tubes are more flexible and cause less irritation than traditional polyvinylchloride tubes.

• The increasing prevalence of chronic diseases such as diabetes, cancer, and gastrointestinal ailments is a key market driver.

• Growing geriatric population and neurological conditions impacting swallowing ability increase the demand for enteral feeding devices.

Sample Request Link: https://www.imarcgroup.com/enteral-feeding-devices-market/requestsample

Market Growth Factors

The global enteral feeding devices market is primarily driven by the rising prevalence of chronic diseases including diabetes, cancer, and gastrointestinal ailments, which necessitate nutritional support through enteral feeding devices. The surging incidence of these diseases increases patient dependence on these devices for delivering balanced nutrients including proteins, carbohydrates, fats, water, minerals, and vitamins directly into the digestive tract.

Another significant growth factor is the expanding elderly population globally, which is more susceptible to chronic medical conditions requiring enteral feeding. Neurological diseases like multiple sclerosis, stroke, and dementia impair patients’ swallowing ability leading to malnourishment, thereby increasing reliance on enteral feeding devices for adequate nutrition.

Technological advancements also contribute to market growth. The development of silicon-based feeding tubes that are more flexible and less irritating compared to traditional polyvinylchloride tubes enhances patient comfort. Innovations such as low-profile gastrostomy buttons for both adults and children facilitate easier tube placement and use. Furthermore, the growing trend of home enteral nutrition and improved healthcare infrastructure drive increasing demand for these devices globally.

Market Segmentation

By Product Type:

• Enteral Feeding Pumps: Devices used to administer nutrients directly into the gastrointestinal tract at controlled rates.

• Enteral Feeding Tubes: Tubes made increasingly from silicon for flexibility and reduced irritation, used for nutrient delivery.

• Giving Sets: Components used in conjunction with feeding pumps and tubes to ensure accurate nutrient delivery.

• Enteral Syringes: Syringes specifically designed for enteral feeding applications for safe nutrient administration.

• Consumables: Supplementary products necessary for the maintenance and operation of enteral feeding devices.

• Others: Additional related products falling under enteral feeding devices.

By Age Group:

• Adults: Devices tailored for adult patients requiring enteral feeding.

• Pediatrics: Devices designed for pediatric patients including neonates and preterm infants.

By Application:

• Oncology: Use in nutritional support for cancer patients.

• Gastroenterology: Devices used in treating gastrointestinal ailments.

• Neurology: Applications involving neurological diseases impacting nutrition intake.

• Diabetes: Nutritional support for diabetic patients.

• Hypermetabolism: Use in conditions involving increased metabolic rates requiring enhanced nutrition.

• Others: Other medical conditions necessitating enteral feeding.

By End User:

• Hospitals: Primary users of enteral feeding devices in clinical settings.

• Ambulatory Surgery Centers: Facilities using these devices for day surgeries and treatments.

• Others: Additional healthcare settings utilizing enteral feeding devices.

By Region:

• North America: Including the United States and Canada.

• Asia Pacific: Countries such as China, Japan, India, South Korea, Australia, Indonesia, and others.

• Europe: Major countries such as Germany, France, United Kingdom, Italy, Spain, Russia, and others.

• Latin America: Including Brazil, Mexico, and others.

• Middle East and Africa: Various countries within these regions.

Regional Insights

North America dominates the enteral feeding devices market, supported by advanced healthcare infrastructure and increasing prevalence of chronic diseases requiring nutritional support. Markets in the United States and Canada significantly contribute to this dominance. The region’s ongoing investments in healthcare innovations and growing geriatric population drive strong market growth and adoption of advanced enteral feeding devices.

Key Players

• Abbott Laboratories

• Amsino International Inc.

• B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG)

• BD (Becton Dickinson and Company)

• Boston Scientific Corporation

• Cardinal Health Inc.

• Conmed Corporation

• Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA)

• Moog Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

👉Get Custom Market Research for Your Business👈

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302